Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Meissa begins pre-clinical studies of Covid-19 intranasal vaccine

pharmaceutical-technologyJuly 02, 2020

Tag: Meissa Vaccines , COVID-19 , MV-014-210 , RSV vaccine

PharmaSources Customer Service